512 related articles for article (PubMed ID: 27581216)
1. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
Rohrer JD; Woollacott IO; Dick KM; Brotherhood E; Gordon E; Fellows A; Toombs J; Druyeh R; Cardoso MJ; Ourselin S; Nicholas JM; Norgren N; Mead S; Andreasson U; Blennow K; Schott JM; Fox NC; Warren JD; Zetterberg H
Neurology; 2016 Sep; 87(13):1329-36. PubMed ID: 27581216
[TBL] [Abstract][Full Text] [Related]
2. Thalamic atrophy in frontotemporal dementia - Not just a
Bocchetta M; Gordon E; Cardoso MJ; Modat M; Ourselin S; Warren JD; Rohrer JD
Neuroimage Clin; 2018; 18():675-681. PubMed ID: 29876259
[TBL] [Abstract][Full Text] [Related]
3. Plasma tau is increased in frontotemporal dementia.
Foiani MS; Woollacott IO; Heller C; Bocchetta M; Heslegrave A; Dick KM; Russell LL; Marshall CR; Mead S; Schott JM; Fox NC; Warren JD; Zetterberg H; Rohrer JD
J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):804-807. PubMed ID: 29440230
[TBL] [Abstract][Full Text] [Related]
4. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.
Heller C; Foiani MS; Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Thomas D; Greaves CV; Woollacott IO; Shafei R; Van Swieten JC; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonca A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Frisoni G; Sorbi S; Otto M; Heslegrave AJ; Zetterberg H; Rohrer JD;
J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):263-270. PubMed ID: 31937580
[TBL] [Abstract][Full Text] [Related]
5. Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia.
Tang M; Gu X; Wei J; Jiao B; Zhou L; Zhou Y; Weng L; Yan X; Tang B; Xu J; Shen L
Neurobiol Aging; 2016 Oct; 46():235.e11-5. PubMed ID: 27311648
[TBL] [Abstract][Full Text] [Related]
6. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.
van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; de Jong FJ; Verberk IMW; Teunissen C; Rizopoulos D; Heller C; Convery RS; Moore KM; Bocchetta M; Neason M; Cash DM; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Carmela Tartaglia M; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Frisoni GB; Cappa S; Pijnenburg YAL; Rohrer JD; van Swieten JC;
Lancet Neurol; 2019 Dec; 18(12):1103-1111. PubMed ID: 31701893
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.
Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL
Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947
[TBL] [Abstract][Full Text] [Related]
8. Serum neurofilament light chain in behavioral variant frontotemporal dementia.
Steinacker P; Anderl-Straub S; Diehl-Schmid J; Semler E; Uttner I; von Arnim CAF; Barthel H; Danek A; Fassbender K; Fliessbach K; Foerstl H; Grimmer T; Huppertz HJ; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Maler JM; Mayer B; Oeckl P; Prudlo J; Schneider A; Volk AE; Wiltfang J; Schroeter ML; Ludolph AC; Otto M;
Neurology; 2018 Oct; 91(15):e1390-e1401. PubMed ID: 30209235
[TBL] [Abstract][Full Text] [Related]
9. Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia.
Giannini LAA; Seelaar H; van der Ende EL; Poos JM; Jiskoot LC; Dopper EGP; Pijnenburg YAL; Willemse EAJ; Vermunt L; Teunissen CE; van Swieten JC; Meeter LH
Neurology; 2023 Sep; 101(10):e1069-e1082. PubMed ID: 37491327
[TBL] [Abstract][Full Text] [Related]
10. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.
Whitwell JL; Boeve BF; Weigand SD; Senjem ML; Gunter JL; Baker MC; DeJesus-Hernandez M; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Jack CR; Josephs KA
Eur J Neurol; 2015 May; 22(5):745-52. PubMed ID: 25683866
[TBL] [Abstract][Full Text] [Related]
11. Modelling the cascade of biomarker changes in
Panman JL; Venkatraghavan V; van der Ende EL; Steketee RME; Jiskoot LC; Poos JM; Dopper EGP; Meeter LHH; Donker Kaat L; Rombouts SARB; Vernooij MW; Kievit AJA; Premi E; Cosseddu M; Bonomi E; Olives J; Rohrer JD; Sánchez-Valle R; Borroni B; Bron EE; Van Swieten JC; Papma JM; Klein S;
J Neurol Neurosurg Psychiatry; 2021 May; 92(5):494-501. PubMed ID: 33452053
[TBL] [Abstract][Full Text] [Related]
12. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
[TBL] [Abstract][Full Text] [Related]
14. Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.
Staffaroni AM; Goh SM; Cobigo Y; Ong E; Lee SE; Casaletto KB; Wolf A; Forsberg LK; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Hsiung GR; Kantarci K; Knopman DS; Kremers WK; Mackenzie IR; Miller BL; Pedraza O; Rascovsky K; Tartaglia MC; Wszolek ZK; Kramer JH; Kornak J; Boeve BF; Boxer AL; Rosen HJ;
JAMA Netw Open; 2020 Oct; 3(10):e2022847. PubMed ID: 33112398
[TBL] [Abstract][Full Text] [Related]
15. Plasma NfL levels and longitudinal change rates in
Saracino D; Dorgham K; Camuzat A; Rinaldi D; Rametti-Lacroux A; Houot M; Clot F; Martin-Hardy P; Jornea L; Azuar C; Migliaccio R; Pasquier F; Couratier P; Auriacombe S; Sauvée M; Boutoleau-Bretonnière C; Pariente J; Didic M; Hannequin D; Wallon D; ; ; Colliot O; Dubois B; Brice A; Levy R; Forlani S; Le Ber I
J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1278-1288. PubMed ID: 34349004
[TBL] [Abstract][Full Text] [Related]
16. Plasma Neurofilament Light Chain in Primary Progressive Aphasia and Related Disorders: Clinical Significance and Metabolic Correlates.
Matías-Guiu JA; Gómez-Pinedo U; Forero L; Pytel V; Cano F; Moreno-Ramos T; Cabrera-Martín MN; Matías-Guiu J; González-Rosa JJ
J Alzheimers Dis; 2019; 72(3):773-782. PubMed ID: 31640103
[TBL] [Abstract][Full Text] [Related]
17. Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia.
Flanagan EP; Baker MC; Perkerson RB; Duffy JR; Strand EA; Whitwell JL; Machulda MM; Rademakers R; Josephs KA
Dement Geriatr Cogn Disord; 2015; 39(5-6):281-6. PubMed ID: 25765123
[TBL] [Abstract][Full Text] [Related]
18. Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias.
Steinacker P; Semler E; Anderl-Straub S; Diehl-Schmid J; Schroeter ML; Uttner I; Foerstl H; Landwehrmeyer B; von Arnim CA; Kassubek J; Oeckl P; Huppertz HJ; Fassbender K; Fliessbach K; Prudlo J; Roßmeier C; Kornhuber J; Schneider A; Volk AE; Lauer M; Danek A; Ludolph AC; Otto M;
Neurology; 2017 Mar; 88(10):961-969. PubMed ID: 28179468
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
20. GRN and MAPT Mutations in 2 Frontotemporal Dementia Research Centers in Brazil.
Takada LT; Bahia VS; Guimarães HC; Costa TV; Vale TC; Rodriguez RD; Porto FH; Machado JC; Beato RG; Cesar KG; Smid J; Nascimento CF; Grinberg LT; Brucki SM; Maximino JR; Camargos ST; Chadi G; Caramelli P; Nitrini R
Alzheimer Dis Assoc Disord; 2016; 30(4):310-317. PubMed ID: 27082848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
